替代生物标志物用于孤儿疾病的基因治疗:验证,应用和监管方面
Aisylu I Ayupova1, Valeriya V Solovyeva1, Shaza S Issa2
1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
International journal of molecular sciences
|October 29, 2025
概括
替代生物标志物通过预测临床结果,加速对罕见疾病的基因疗法评估. 这篇评论涵盖了它们的验证,全球法规,以及人工智能和多方经济的未来潜力.
科学领域:
- 生物医学科学 生物医学科学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 对罕见遗传性疾病的基因疗法开发面临诸如小患者群和漫长的临床试验等挑战.
- 替代生物标志物提供了一个解决方案,通过提供可量化的指标预测临床结果,可能加快治疗评估.
研究的目的:
- 审查代理终点在推进罕见疾病基因疗法的关键作用.
- 概述替代生物标记物的基本验证标准,包括生物可信性,分析可重复性和临床预测价值.
主要方法:
- 对美国,欧盟,俄罗斯,日本,中国和加拿大的代孕标记物的监管框架进行比较分析.
- 讨论罕见疾病生物标志物验证和推断方面的挑战.
主要成果:
- 确定了基因治疗中替代生物标志物的关键验证标准.
- 比较国际监管方法,突出加速或有条件批准的途径.
结论:
- 替代生物标志物对于在罕见疾病中有效的基因疗法评估至关重要.
- 未来的方向包括整合多领域和人工智能,以改善生物标志物发现和监管接受.
更多相关视频
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
893
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
18.3K
相关概念视频
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Drug Products: Biologics, Biosimilars and Interchangeables
229
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
229
